Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of celecoxib capsules under fasting conditions
TCTR20201211001Phase 1Not yet recruiting
- Sponsor
- T.O. Chemicals
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of celecoxib (2 arms), sponsored by T.O. Chemicals. Primary endpoints: Cmax, AUC0-t and 1 more. Planned start Mar 2021; status: not yet recruiting.
02
Drugs
celecoxib
Beyond the preview
Go deeper on TCTR20201211001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20201211001.